BEUDAMED
    12 results · 20ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    TIMESH TITANIUM MINI-SOFTPLATE/SCREW

    FDA 510(k)
    FDA Class 2 ·Dental

    VARIO-PORT

    FDA UDI
    Richard Wolf GmbH·04055207022481·REDUCTION ADAPTER for reduction from Ø 7mm, Ø ...

    SYNTHES 4.5 MM TITANIUM LCP PROXIMAL TIBIA PLATING SYSTEM

    FDA 510(k)
    FDA Class 2 ·Orthopedic

    EASYRA TBIL REAGENT, EASYRA DBII REAGENT, EASYRA CK REAGENT

    FDA 510(k)
    FDA Class 2 ·Clinical Chemistry

    LATERAL STRAIGHT STEM 15.0 12/14

    FDA Adverse Event
    Injury ·ZIMMER GMBH·Product code KWB·March 28, 2012

    PROLENE POLYPROPYLENE MESH

    FDA Adverse Event
    Injury ·ETHICON, INC.·Product code FTL·January 22, 2013

    CLEARLINK SYSTEM EXTENSION SET

    FDA Adverse Event
    Malfunction ·BAXTER HEALTHCARE - CLEVELAND·Product code FPA·December 14, 2010

    LTV

    FDA Adverse Event
    Malfunction ·CAREFUSION 203, INC·Product code CBK·July 9, 2014

    SULOX-HD 32 M 12/14

    FDA Adverse Event
    Injury ·ZIMMER GMBH·Product code LZO·April 23, 2019

    SULOX, HEAD, M¸ 32/0, TAPER 12/14

    FDA Adverse Event
    Injury ·ZIMMER GMBH·Product code KWB·August 3, 2018

    SULOX-HEAD 28 M 12/14

    FDA Adverse Event
    Injury ·ZIMMER GMBH·Product code LPH·April 4, 2019

    Footswitch accessory to the CUSA Clarity Ultrasonic Tissue Ablation System; Catalogue No: C7000 Product Usage: The footswitch is a component of the CUSA Clarity Ultrasonic Surgical Aspirator System, which is indicated for use in surgical procedures where fragmentation, emulsification and aspiration of soft tissue is desirable. The CUSA Clarity Ultrasonic Surgical Aspirator is indicated for use in: Neurosurgery, Plastic and Reconstructive surgery, Orthopedic Surgery, Gynecological Surgery and Thoracic Surgery and the following specific uses are cleared for use in the US only: Gastrointestinal and Affiliated Organ Surgery including removal of benign or malignant tumors or other unwanted tissue, including hepatic parenchyma, in open or laparoscopic procedures, hepatic resection, tumor resection, lobectomy or trisegmentectomy, or removal of tissue during liver allotransplantation and donor hepatectomy Urological surgery including removal of renal parenchyma during nephrectomy or partial nephrectomy General Surgery including removal of benign or malignant tumors or other unwanted soft tissue in open or minimally invasive general surgical procedures Laparoscopic Surgery including removal of hepatic parenchyma in laparoscopic hepatic resection, lobectomy or trisegmentectomy, in laparoscopic donor hepatectomy or laparoscopic cholecystectomy or laparoscopic pancreatic jejunostomy, or pancreatectomy, or laparoscopic appendectomy, laparoscopic colon resection or laparoscopic partial gastrectomy.

    FDA Enforcement
    Class II ·Terminated·Integra LifeSciences Corp.·March 7, 2018